Dmitry Zamansky, who serves as Chief Product & Technology Officer at American Well Corp (NYSE: AMWL), sold 5,575 shares of the company’s Class A common stock on April 1, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The shares traded at $5.30 apiece, producing proceeds of $29,547.
Following the transaction, Zamansky’s direct holdings total 241,080 shares. The filing specifies the sale was executed to satisfy the tax withholding obligation that arose when restricted stock units vested and were settled on April 1, 2026. The trade was carried out automatically as a "sell to cover" and was not a discretionary sale initiated by Zamansky.
Financial metrics disclosed by the company underscore ongoing headwinds. Over the last twelve months Amwell reported a loss per share of $5.96 and recorded negative free cash flow of $65.97 million. Separately, the company reported a 22.1% year-over-year drop in revenue for the fourth quarter of 2025.
Despite those pressures, Amwell ended the reporting period with $182 million in cash and no debt on the balance sheet. The company’s emphasis on technology and integration of artificial intelligence into its offerings has been noted as a factor supporting investor sentiment, and the stock registered a 2.55% gain following the recent updates.
Additional analysis and tips on the company’s financial health and outlook are available via InvestingPro, which lists five supplementary items related to AMWL’s position.
What happened
- An automatic sell-to-cover on April 1, 2026, saw 5,575 shares sold at $5.30 for $29,547.
- The sale covered tax liabilities tied to RSU vesting and settlement on the same date and was non-discretionary.
Where the company stands
- Amwell reported a 22.1% revenue decline in Q4 2025 and a trailing twelve-month loss per share of $5.96.
- Free cash flow was negative $65.97 million, while year-end cash totaled $182 million with no outstanding debt.
- The stock moved up 2.55% amid investor attention to the company’s technology and AI integration.
These items together outline the immediate context for the insider transaction and the broader financial snapshot disclosed by the company.